Literature DB >> 13129419

Preoperative and intraoperative factors predictive of length of hospital stay after pulmonary lobectomy.

Andrei Gagarine1, John D Urschel, John D Miller, W Frederick Bennett, J Edward M Young.   

Abstract

BACKGROUND: Length of hospital stay is an important determinant of overall surgical costs. Health care resources are finite, so reductions in length of stay are desirable. We reviewed our experience with pulmonary lobectomy to identify preoperative and intraoperative factors that predicted the length of postoperative hospital stay. By identifying these factors, we hoped to favorably influence future patient management.
METHODS: Records of patients undergoing pulmonary lobectomy for benign or malignant disease over a four-year period (1998-2001) were reviewed. Data was collected on age, sex, pulmonary function, pulmonary pathology, cigarette smoking, type of thoracotomy incision, use of surgical sealants, surgeon, and length of hospital stay.
RESULTS: Three hundred and sixty patients underwent lobectomy. Forward stepwise regression identified age (p=0.022), FEV1 (forced expiratory volume in one second) (p=0.047), diffusion capacity (p=0.020), and surgeon (p<0.001) as independent factors predictive of hospital length of stay. When these four factors were analyzed in a multiple linear regression model, the surgeon variable emerged as the strongest predictor of length of stay (p<0.001).
CONCLUSIONS: Although patient factors were influential, the individual surgeon was the most important determinant of hospital length of stay after pulmonary lobectomy. It may be possible to reduce length of hospital stay by identifying variations in practice within the surgical group, and encouraging widespread adoption of "best practice" surgical techniques.

Entities:  

Mesh:

Year:  2003        PMID: 13129419

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  3 in total

1.  Thromboprophylaxis for lung cancer patients--multimodality assessment of clinician practices, perceptions and decision support tools.

Authors:  M Alexander; S Kirsa; M MacManus; D Ball; B Solomon; K Burbury
Journal:  Support Care Cancer       Date:  2014-02-27       Impact factor: 3.603

2.  A population-based study of hospital length of stay and emergency readmission following surgery for non-small-cell lung cancer.

Authors:  Joseph McDevitt; Maria Kelly; Harry Comber; Tracey Kelleher; Fiona Dwane; Linda Sharp
Journal:  Eur J Cardiothorac Surg       Date:  2013-07-25       Impact factor: 4.191

3.  Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study.

Authors:  Seung Won Song; Kyung Yeon Yoo; Yong Sung Ro; Taehee Pyeon; Hong-Beom Bae; Joungmin Kim
Journal:  J Cardiothorac Surg       Date:  2021-03-23       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.